Quick Takeaways
- Yu-Hsin Lin filed SCHEDULE 13G for BELITE BIO, INC Ordinary shares, par value US$0.0001 per share (BLTE).
- Disclosed ownership: 7.1%.
- Date of event: 31 Dec 2024.
Yu-Hsin Lin - 31 Dec 2024 SCHEDULE 13G Report for BELITE BIO, INC Ordinary shares, par value US$0.0001 per share (BLTE)
- Filing Manager
- Yu-Hsin Lin
- Reporting Manager
- Yu-Hsin Lin
- Symbol
- BLTE
- Shares outstanding
- 32,212,254 shares
- Disclosed Ownership
- 2,287,070 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 21 Jan 2025, 06:02:09 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Yu-Hsin Lin disclosed 7.1% ownership in BELITE BIO, INC Ordinary shares, par value US$0.0001 per share (BLTE) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Jan 2025, 06:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Yu-Hsin Lin | 7.1% | 2,287,070 | 2,287,070 | 0 | /s/ Yu-Hsin Lin | Yu-Hsin Lin,Chief Executive Officer and Chairman |